These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 35801984)
1. A review on artificial pancreas and regenerative medicine used in the management of Type 1 diabetes mellitus. Sachdeva P; M AR; Shukla R; Sahani A J Med Eng Technol; 2022 Nov; 46(8):693-702. PubMed ID: 35801984 [TBL] [Abstract][Full Text] [Related]
2. Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial. Russell SJ; Hillard MA; Balliro C; Magyar KL; Selagamsetty R; Sinha M; Grennan K; Mondesir D; Ekhlaspour L; Zheng H; Damiano ER; El-Khatib FH Lancet Diabetes Endocrinol; 2016 Mar; 4(3):233-243. PubMed ID: 26850709 [TBL] [Abstract][Full Text] [Related]
3. Development and Future of Automated Insulin Delivery (AID) Systems. Garg SK; McVean JJ Diabetes Technol Ther; 2024 Mar; 26(S3):1-6. PubMed ID: 38377322 [No Abstract] [Full Text] [Related]
4. Changes in Ambulatory Glucose Profile in Patients With Type 1 Diabetes Mellitus After Switching From Sensor-Augmented Insulin Pump Therapy to a Do-It-Yourself Artificial Pancreas System: A Retrospective Data Analysis of Real-World Data. Müller-Korbsch M; Frühwald L; Kietaibl A J Diabetes Sci Technol; 2022 Nov; 16(6):1577-1579. PubMed ID: 35915931 [No Abstract] [Full Text] [Related]
5. Performance of the Insulin-Only iLet Bionic Pancreas and the Bihormonal iLet Using Dasiglucagon in Adults With Type 1 Diabetes in a Home-Use Setting. Castellanos LE; Balliro CA; Sherwood JS; Jafri R; Hillard MA; Greaux E; Selagamsetty R; Zheng H; El-Khatib FH; Damiano ER; Russell SJ Diabetes Care; 2021 Jun; 44(6):e118-e120. PubMed ID: 33906916 [No Abstract] [Full Text] [Related]
6. Use of the Interoperable Artificial Pancreas System for Type 1 Diabetes Management During Psychological Stress. Pinsker JE; Deshpande S; McCrady-Spitzer S; Church MM; Kaur RJ; Perez J; Desjardins D; Piper M; Reid C; Doyle FJ; Kudva YC; Dassau E J Diabetes Sci Technol; 2021 Jan; 15(1):184-185. PubMed ID: 32783473 [No Abstract] [Full Text] [Related]
7. The artificial pancreas: current status and future prospects in the management of diabetes. Peyser T; Dassau E; Breton M; Skyler JS Ann N Y Acad Sci; 2014 Apr; 1311():102-23. PubMed ID: 24725149 [TBL] [Abstract][Full Text] [Related]
8. [What is the current state of the artificial pancreas in diabetes care?]. Dimou M; Laimer M; Stettler C; Bally L Internist (Berl); 2020 Jan; 61(1):102-109. PubMed ID: 31863132 [TBL] [Abstract][Full Text] [Related]
9. An artificial pancreas for automated blood glucose control in patients with Type 1 diabetes. Schmidt S; Boiroux D; Ranjan A; Jørgensen JB; Madsen H; Nørgaard K Ther Deliv; 2015; 6(5):609-19. PubMed ID: 26001176 [TBL] [Abstract][Full Text] [Related]
10. [From insulin pump and continuous glucose monitoring to the artificial pancreas]. Apablaza P; Soto N; Codner E Rev Med Chil; 2017 May; 145(5):630-640. PubMed ID: 28898340 [TBL] [Abstract][Full Text] [Related]
11. New and Emerging Technologies in Type 1 Diabetes. Sherwood JS; Russell SJ; Putman MS Endocrinol Metab Clin North Am; 2020 Dec; 49(4):667-678. PubMed ID: 33153673 [TBL] [Abstract][Full Text] [Related]
12. Type 1 diabetes: NICE recommends new "artificial pancreas" technology. Iacobucci G BMJ; 2023 Jan; 380():55. PubMed ID: 36627118 [No Abstract] [Full Text] [Related]
13. Current topics in glycemic control by wearable artificial pancreas or bedside artificial pancreas with closed-loop system. Hanazaki K; Munekage M; Kitagawa H; Yatabe T; Munekage E; Shiga M; Maeda H; Namikawa T J Artif Organs; 2016 Sep; 19(3):209-18. PubMed ID: 27142278 [TBL] [Abstract][Full Text] [Related]
14. Who needs an artificial pancreas? (?). Winikoff J; Drexler A J Diabetes; 2013 Sep; 5(3):254-7. PubMed ID: 23601378 [TBL] [Abstract][Full Text] [Related]
15. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial. Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967 [TBL] [Abstract][Full Text] [Related]
16. Do-It-Yourself Artificial Pancreas System Use in Pregnant Women With Type 1 Diabetes in a Real-World Setting: 2 Case Reports. Lemieux P; Yamamoto JM; Donovan LE Can J Diabetes; 2021 Dec; 45(8):804-808.e2. PubMed ID: 33648862 [No Abstract] [Full Text] [Related]
17. Technological advances in the treatment of diabetes mellitus: better bioengineering begets benefits in glucose measurement, the artificial pancreas, and insulin delivery. Klonoff DC Pediatr Endocrinol Rev; 2003 Dec; 1(2):94-100. PubMed ID: 16437014 [TBL] [Abstract][Full Text] [Related]
18. How It Started, How It Is Going: The Future of Artificial Pancreas Systems (Automated Insulin Delivery Systems). Lewis D J Diabetes Sci Technol; 2021 Nov; 15(6):1258-1261. PubMed ID: 34218717 [TBL] [Abstract][Full Text] [Related]
19. Automated Insulin Dosing Systems or Automated Insulin Delivery Systems? It is Time for Consistency. Klonoff DC; Shang T; Zhang J J Diabetes Sci Technol; 2021 Mar; 15(2):211-213. PubMed ID: 33650456 [No Abstract] [Full Text] [Related]
20. Artificial Pancreas Improved Outcomes in Children With Type 1 Diabetes. Harris E JAMA; 2023 Apr; 329(15):1249. PubMed ID: 36988977 [No Abstract] [Full Text] [Related] [Next] [New Search]